Skip to main content
Log in

Impact of the polymorphism in vitamin D receptor gene BsmI and the risk of systemic lupus erythematosus: an updated meta-analysis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The etiology of system lupus erythematosus (SLE) still remains unclear, and vitamin D is associated with immune response. Although a few studies are conducted to investigate the association between polymorphism in vitamin D receptor (VDR) genes and SLE risk, their results are conflicting. Following the guideline of PRISMA, we conducted a systematic search and meta-analysis of the BsmI polymorphism rs1544410 and the risk of SLE. The pooled odds ratios (OR) and its 95 % confidential interval (CI) were calculated by using Stata Version 10 with dominant and recessive model and allele analyses. Nine studies were included in our meta-analysis with a total of 1247 SLE cases and 1687 controls. No significant association was found in both models in the overall population. Only Bb + BB genotypes showed a significantly elevated SLE risk in Asian subgroup with an OR of 3.26 (95 % CI = 1.30–8.17) while no significance was observed in Caucasian population. Notably, B allele significantly increased the SLE risk among Asian population with an OR of 2.29 (95 % CI = 1.14–4.61). No positive findings were reported in Caucasian population and in the overall analysis. In Asian population, Bb + BB genotype and B allele can significantly increase the SLE risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Choi J, Kim ST, Craft J (2012) The pathogenesis of systemic lupus erythematosus—an update. Curr Opin Immunol 24(6):651–657

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Lisnevskaia L, Murphy G, Isenberg D (2014) Systemic lupus erythematosus. Lancet 384(9957):1878–1888

    Article  PubMed  Google Scholar 

  3. D’Cruz DP, Khamashta MA, Hughes GR (2007) Systemic lupus erythematosus. Lancet 369(9561):587–596

    Article  PubMed  Google Scholar 

  4. Zandman-Goddard G, Solomon M, Rosman Z et al (2012) Environment and lupus-related diseases. Lupus 21(3):241–250

    Article  CAS  PubMed  Google Scholar 

  5. Harley JB, Kelly JA, Kaufman KM (2006) Unraveling the genetics of systemic lupus erythematosus. Springer Semin Immunopathol 28(2):119–130

    Article  CAS  PubMed  Google Scholar 

  6. Bogdanos DP, Smyk DS, Rigopoulou EI et al (2012) Twin studies in autoimmune disease: genetics, gender and environment. J Autoimmun 38(2–3):J156–J169

    Article  PubMed  Google Scholar 

  7. Hristova M, Dourmishev L, Kamenarska Z et al (2013) Role of the promoter polymorphism IL-6 -174G/C in dermatomyositis and systemic lupus erythematosus. Biomed Res Int 2013:315365

    Article  PubMed  PubMed Central  Google Scholar 

  8. Webb R, Merrill JT, Kelly JA et al (2009) A polymorphism within IL21R confers risk for systemic lupus erythematosus. Arthritis Rheum 60(8):2402–2407

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Warchoł T, Mostowska A, Lianeri M et al (2012) XRCC1 Arg399Gln gene polymorphism and the risk of systemic lupus erythematosus in the Polish population. DNA Cell Biol 31(1):50–56

    Article  PubMed  PubMed Central  Google Scholar 

  10. Hawn TR, Wu H, Grossman JM et al (2005) A stop codon polymorphism of Toll-like receptor 5 is associated with resistance to systemic lupus erythematosus. Proc Natl Acad Sci U S A 102(30):10593–10597

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Takahashi R, Tsutsumi A, Ohtani K et al (2005) Association of mannose binding lectin (MBL) gene polymorphism and serum MBL concentration with characteristics and progression of systemic lupus erythematosus. Ann Rheum Dis 64(2):311–314

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Moher D, Liberati A, Tetzlaff J et al (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8(5):336–341

    Article  PubMed  Google Scholar 

  13. Ozaki Y, Nomura S, Nagahama M et al (2000) Vitamin-D receptor genotype and renal disorder in Japanese patients with systemic lupus erythematosus. Nephron 85(1):86–91

    Article  CAS  PubMed  Google Scholar 

  14. Huang CM, Wu MC, Wu JY et al (2002) Association of vitamin D receptor gene BsmI polymorphisms in Chinese patients with systemic lupus erythematosus. Lupus 11(1):31–34

    Article  CAS  PubMed  Google Scholar 

  15. Sakulpipatsin W, Verasertniyom O, Nantiruj K et al (2006) Vitamin D receptor gene BsmI polymorphisms in Thai patients with systemic lupus erythematosus. Arthritis Res Ther 8(2):R48

    Article  PubMed  PubMed Central  Google Scholar 

  16. Abbasi M, Rezaieyazdi Z, Afshari JT et al (2010) Lack of association of vitamin D receptor gene BsmI polymorphisms in patients with systemic lupus erythematosus. Rheumatol Int 30(11):1537–1539

    Article  CAS  PubMed  Google Scholar 

  17. Luo XY, Yang MH, Wu FX et al (2012) Vitamin D receptor gene BsmI polymorphism B allele, but not BB genotype, is associated with systemic lupus erythematosus in a Han Chinese population. Lupus 21(1):53–59

    Article  CAS  PubMed  Google Scholar 

  18. Monticielo OA, Brenol JC, Chies JA et al (2012) The role of BsmI and FokI vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D in Brazilian patients with systemic lupus erythematosus. Lupus 21(1):43–52

    Article  CAS  PubMed  Google Scholar 

  19. Kaleta B, Bogaczewicz J, Robak E et al (2013) Vitamin D receptor gene BsmI polymorphism in polish patients with systemic lupus erythematosus. ISRN Endocrinol 2013:427818

    Article  PubMed  PubMed Central  Google Scholar 

  20. Mostowska A, Lianeri M, Wudarski M et al (2013) Vitamin D receptor gene BsmI, FokI, ApaI and TaqI polymorphisms and the risk of systemic lupus erythematosus. Mol Biol Rep 40(2):803–810

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Carvalho C, Marinho A, Leal B et al (2015) Association between vitamin D receptor (VDR) gene polymorphisms and systemic lupus erythematosus in Portuguese patients. Lupus 24(8):846–853

    Article  CAS  PubMed  Google Scholar 

  22. Holick MF (2004) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80(6 Suppl):1678S–1688S

    CAS  PubMed  Google Scholar 

  23. Grant WB (2006) Epidemiology of disease risks in relation to vitamin D insufficiency. Prog Biophys Mol Biol 92(1):65–79

    Article  CAS  PubMed  Google Scholar 

  24. Lemire JM, Ince A, Takashima M (1992) 1,25-Dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL/l mice. Autoimmunity 12(2):143–148

    Article  CAS  PubMed  Google Scholar 

  25. Ritterhouse LL, Crowe SR, Niewold TB et al (2011) Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus. Ann Rheum Dis 70(9):1569–1574

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. O’Regan S, Chesney RW, Hamstra A et al (1979) Reduced serum 1,25-(OH)2 vitamin D3 levels in prednisone-treated adolescents with systemic lupus erythematosus. Acta Paediatr Scand 68(1):109–111

    Article  PubMed  Google Scholar 

  27. Hamza RT, Awwad KS, Ali MK et al (2011) Reduced serum concentrations of 25-hydroxy vitamin D in Egyptian patients with systemic lupus erythematosus: relation to disease activity. Med Sci Monit 17(12):CR711–CR718

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. McGhie TK, DeCeulaer K, Walters CA et al (2014) Vitamin D levels in Jamaican patients with systemic lupus erythematosus. Lupus 23(10):1092–1096

    Article  CAS  PubMed  Google Scholar 

  29. Garf KE, Marzouk H, Farag Y et al (2015) Vitamin D status in Egyptian patients with juvenile-onset systemic lupus erythematosus. Rheumatol Int 35(9):1535–1540

    Article  PubMed  Google Scholar 

  30. Yap KS, Northcott M, Hoi AB et al (2015) Association of low vitamin D with high disease activity in an Australian systemic lupus erythematosus cohort. Lupus Sci Med 2(1):e000064

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Morrison NA, Qi JC, Tokita A et al (1994) Prediction of bone density from vitamin D receptor alleles. Nature 367(6460):284–287

    Article  CAS  PubMed  Google Scholar 

  32. Alroy I, Towers TL, Freedman LP (1995) Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol 15(10):5789–5799

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Lemire JM, Adams JS, Kermani-Arab V et al (1985) 1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. J Immunol 134(5):3032–3035

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This research was supported by grants from Fujian Provincial Health and Family Planning Commission (No.2014ZQNZD19) and National Natural Science Foundation of China (No.81302589).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ling Lin.

Ethics declarations

Disclosures

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hu, W., Niu, G., Lin, Y. et al. Impact of the polymorphism in vitamin D receptor gene BsmI and the risk of systemic lupus erythematosus: an updated meta-analysis. Clin Rheumatol 35, 927–934 (2016). https://doi.org/10.1007/s10067-015-3157-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-015-3157-x

Keywords

Navigation